Cargando…

The development of a solid lipid nanoparticle (SLN)-based lacticin 3147 hydrogel for the treatment of wound infections

Chronic wounds affect millions of people globally. This number is set to rise with the increasing incidence of antimicrobial-resistant bacterial infections, such as methicillin-resistant Staphylococcus aureus (MRSA), which impair the healing of chronic wounds. Lacticin 3147 is a two-peptide chain ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryan, Aoibhín, Patel, Pratikkumar, Ratrey, Poonam, O’Connor, Paula M., O’Sullivan, Julie, Ross, R. Paul, Hill, Colin, Hudson, Sarah P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382363/ https://www.ncbi.nlm.nih.gov/pubmed/36964439 http://dx.doi.org/10.1007/s13346-023-01332-9

Ejemplares similares

Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147
por: Ryan, Aoibhín, et al.
Publicado: (2021)

Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
por: O'Connor, Eileen B, et al.
Publicado: (2007)

Manipulation of charged residues within the two‐peptide lantibiotic lacticin 3147
por: Deegan, Lucy H., et al.
Publicado: (2010)

The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
por: Draper, Lorraine A, et al.
Publicado: (2013)

The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model
por: Piper, Clare, et al.
Publicado: (2012)

Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity
por: Field, Des, et al.
Publicado: (2013)

Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147
por: Crispie, Fiona, et al.
Publicado: (2004)

Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis
por: Musielak, Ewelina, et al.
Publicado: (2022)

The nature of the low-luminosity AGN in NGC 3147
por: Ptak, A, et al.
Publicado: (1995)

A Live Bio-Therapeutic for Mastitis, Containing Lactococcus lactis DPC3147 With Comparable Efficacy to Antibiotic Treatment
por: Kitching, Michael, et al.
Publicado: (2019)

Lacticin 481 Synthetase as a General Serine/Threonine Kinase
por: You, Young Ok, et al.
Publicado: (2009)

3147 Electroencephalographic suppression from anesthesia and cognitive recovery
por: Hickman, Leonard Brian, et al.
Publicado: (2019)

Chemical Synthesis of the Lantibiotic Lacticin 481 Reveals the Importance of Lanthionine Stereochemistry
por: Knerr, Patrick J., et al.
Publicado: (2013)

Demographic and Diagnostic Features of 3147 Inpatients With Mood Disorders in Iran
por: Ghanbari Jolfaei, Atefeh, et al.
Publicado: (2016)

Spherical inversion on SLn(R)
por: Jorgenson, Jay, et al.
Publicado: (2001)

Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery
por: Xing, R., et al.
Publicado: (2021)

Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
por: Üner, Melike, et al.
Publicado: (2007)

Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicity
por: Oehlke, Kathleen, et al.
Publicado: (2017)

In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
por: Costa, Cláudia Pina, et al.
Publicado: (2021)

Polydopamine Antioxidant Hydrogels for Wound Healing Applications
por: O’Connor, Naphtali A., et al.
Publicado: (2020)

Non-proteinogenic Amino Acids in Lacticin 481 Analogues Result in More Potent Inhibition of Peptidoglycan Transglycosylation
por: Knerr, Patrick J., et al.
Publicado: (2012)

Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens
por: O'Sullivan, Julie N, et al.
Publicado: (2018)

Bactofencin A, a New Type of Cationic Bacteriocin with Unusual Immunity
por: O'Shea, Eileen F., et al.
Publicado: (2013)

Development and Optimization of Alpha-Pinene-Loaded Solid Lipid Nanoparticles (SLN) Using Experimental Factorial Design and Dispersion Analysis
por: Zielińska, Aleksandra, et al.
Publicado: (2019)

Short Term Stability Testing of Efavirenz-Loaded Solid Lipid Nanoparticle (SLN) and Nanostructured Lipid Carrier (NLC) Dispersions
por: Makoni, Pedzisai A., et al.
Publicado: (2019)

Enhancing Aqueous Solubility and Antibacterial Activity of Curcumin by Complexing with Cell-Penetrating Octaarginine
por: Ratrey, Poonam, et al.
Publicado: (2020)

miR-3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression
por: Yang, Xiu-Hua, et al.
Publicado: (2018)

Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma
por: Grotz, Travis E, et al.
Publicado: (2015)

Chitosan-Coated SLN: A Potential System for Ocular Delivery of Metronidazole
por: Sikhondze, Simise S., et al.
Publicado: (2023)

Nisin J, a Novel Natural Nisin Variant, Is Produced by Staphylococcus capitis Sourced from the Human Skin Microbiota
por: O’Sullivan, Julie N., et al.
Publicado: (2020)

Moisturizing effects of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) using deionized and magnetized water by in vivo and in vitro methods
por: Sarhadi, Susan, et al.
Publicado: (2020)

Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active
por: Sakellari, Georgia I., et al.
Publicado: (2021)

Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) Prepared by Microwave and Ultrasound-Assisted Synthesis: Promising Green Strategies for the Nanoworld
por: López, Karla L., et al.
Publicado: (2023)

Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery
por: Souto, Eliana B., et al.
Publicado: (2022)

Increased Therapeutic Efficacy of SLN Containing Etofenamate and Ibuprofen in Topical Treatment of Inflammation
por: Mancini, Giuliana, et al.
Publicado: (2021)

Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
por: Mengeste, Abel M., et al.
Publicado: (2022)

PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
por: Sherif, Abdelrahman Y, et al.
Publicado: (2022)

Bacteriocin Gene-Trait matching across the complete Lactobacillus Pan-genome
por: Collins, Fergus W. J., et al.
Publicado: (2017)

SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study
por: Migliano, Emilia, et al.
Publicado: (2013)

Evaluation of the antibacterial activity of tilmicosin-SLN against Streptococcus agalactiae: in vitro and in vivo studies
por: Zhu, Luyan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_trcdqeit58iifeegukmdp18kp0